-
Molecular imaging links late-life depression to neurotransmitter and Alzheimer’s changes
Molecular imaging reveals late-life depression involves altered neurotransmitter systems, Alzheimer's pathology, and neuroinflammation, supporting development of targeted mechanism-based treatments.
-
Reasoning-based LLMs may predict antidepressant response
Study evaluates reasoning-based large language models for predicting 12-week remission in depressive disorder patients undergoing antidepressant monotherapy.
